Skip to main content


Interparfums FY 2022: record earnings as operating profit soars 33 percent

THE WHAT? Interparfums has reported its results for the 2022 fiscal year. The fragrance giant recorded record earnings for the full year with net income up 40 percent on 2021’s figures and sales rising 26 percent to €706.6 million. THE DETAILS The company noted that it had extended its partnership with Montblanc until December 31, 2030 and, subject to the General Meeting’s ratification, hit its goal of achieving gender parity on its board. THE WHY? Philippe Benacin, Chairman and CEO, commented, “Against the backdrop of a turbulent economic and geopolitical environment, our sales and earnings continued to grow in 2022. In 2023, although many uncertainties still exist, this positive momentum should continue with sales expected to reach €750 million, driven by the continuing appeal of our brands for consumers in a global perfume market that remains buoyant.” The post Interparfums FY 2022: record earnings as operating profit soars 33 percent appeared first on Global Cosme

Trump Wanted FDA To Fast-Track Blood Plasma Therapy. What Is It?

Convalescent serum or blood plasma from a recovered COVID-19 patients is being studied as a treatment for others with the disease. The FDA is holding off on giving it emergency use authorization.

The president criticized the FDA this week for not giving emergency use approval to an experimental treatment for COVID-19. Scientists argue that the therapy still lacks sufficient evidence.

(Image credit: Arnulfo Franco/AP)

* This article was originally published here


Popular Posts